RSS-Feed abonnieren
DOI: 10.1055/s-0031-1291373
Piecing Together the Humoral and Cellular Mechanisms of Immune Thrombocytopenia
Publikationsverlauf
Publikationsdatum:
18. November 2011 (online)

Abstract
The precise mechanisms leading to platelet-targeted autoimmunity in immune thrombocytopenia (ITP) are not known. Cellular checkpoints normally regulate immunological self-reactivity during the development of B and T cells through cell deletion, receptor editing, induction of anergy, and extrinsic cellular suppression. When these checkpoints fail, tolerance to self-antigens may be lost. In this review, we summarize the various immune mechanisms contributing to the development of ITP and relate them back to the checkpoint model of autoimmunity. These mechanisms, including increased levels of lymphocyte growth factors, resistance to death signals, and loss of T-regulatory function, result in an environment permissive to the development of platelet-reactive B and T cells. The mechanisms that lead to thrombocytopenia once tolerance for platelet antigens is lost are examined, including complement-dependent and apoptotic pathways. An improved understanding of ITP pathogenesis will ultimately guide the development of better therapies.
KEYWORDS
Immune thrombocytopenia - self-tolerance - platelets - megakaryocytes - autoantibody
REFERENCES
- 1
Warner M N, Moore J C, Warkentin T E, Santos A V, Kelton J G.
A prospective study of protein-specific assays used to investigate idiopathic thrombocytopenic
purpura.
Br J Haematol.
1999;
104
(3)
442-447
MissingFormLabel
- 2
McMillan R.
Antiplatelet antibodies in chronic adult immune thrombocytopenic purpura: assays and
epitopes.
J Pediatr Hematol Oncol.
2003;
25
(Suppl 1)
S57-S61
MissingFormLabel
- 3
Cines D B, Bussel J B, Liebman H A, Luning Prak E T.
The ITP syndrome: pathogenic and clinical diversity.
Blood.
2009;
113
(26)
6511-6521
MissingFormLabel
- 4
Goodnow C C, Sprent J, Fazekas de St Groth B, Vinuesa C G.
Cellular and genetic mechanisms of self tolerance and autoimmunity.
Nature.
2005;
435
(7042)
590-597
MissingFormLabel
- 5
Hartley S B, Cooke M P, Fulcher D A et al..
Elimination of self-reactive B lymphocytes proceeds in two stages: arrested development
and cell death.
Cell.
1993;
72
(3)
325-335
MissingFormLabel
- 6
Hsu B L, Harless S M, Lindsley R C, Hilbert D M, Cancro M P.
Cutting edge: BLyS enables survival of transitional and mature B cells through distinct
mediators.
J Immunol.
2002;
168
(12)
5993-5996
MissingFormLabel
- 7
Thien M, Phan T G, Gardam S et al..
Excess BAFF rescues self-reactive B cells from peripheral deletion and allows them
to enter forbidden follicular and marginal zone niches.
Immunity.
2004;
20
(6)
785-798
MissingFormLabel
- 8
Cheema G S, Roschke V, Hilbert D M, Stohl W.
Elevated serum B lymphocyte stimulator levels in patients with systemic immune-based
rheumatic diseases.
Arthritis Rheum.
2001;
44
(6)
1313-1319
MissingFormLabel
- 9
Zhang J, Roschke V, Baker K P et al..
Cutting edge: a role for B lymphocyte stimulator in systemic lupus erythematosus.
J Immunol.
2001;
166
(1)
6-10
MissingFormLabel
- 10
Groom J, Kalled S L, Cutler A H et al..
Association of BAFF/BLyS overexpression and altered B cell differentiation with Sjögren's
syndrome.
J Clin Invest.
2002;
109
(1)
59-68
MissingFormLabel
- 11
Emmerich F, Bal G, Barakat A et al..
High-level serum B-cell activating factor and promoter polymorphisms in patients with
idiopathic thrombocytopenic purpura.
Br J Haematol.
2007;
136
(2)
309-314
MissingFormLabel
- 12
Zhu X J, Shi Y, Sun J Z et al..
High-dose dexamethasone inhibits BAFF expression in patients with immune thrombocytopenia.
J Clin Immunol.
2009;
29
(5)
603-610
MissingFormLabel
- 13
Zhu X J, Shi Y, Peng J et al..
The effects of BAFF and BAFF-R-Fc fusion protein in immune thrombocytopenia.
Blood.
2009;
114
(26)
5362-5367
MissingFormLabel
- 14
Zhou Z, Chen Z, Li H et al..
BAFF and BAFF-R of peripheral blood and spleen mononuclear cells in idiopathic thrombocytopenic
purpura.
Autoimmunity.
2009;
42
(2)
112-119
MissingFormLabel
- 15
Gu D, Ge J, Du W et al..
Raised expression of APRIL in Chinese patients with immune thrombocytopenia and its
clinical implications.
Autoimmunity.
2009;
42
(8)
692-698
MissingFormLabel
- 16
Palmer E.
Negative selection—clearing out the bad apples from the T-cell repertoire.
Nat Rev Immunol.
2003;
3
(5)
383-391
MissingFormLabel
- 17
Sakaguchi N, Takahashi T, Hata H et al..
Altered thymic T-cell selection due to a mutation of the ZAP-70 gene causes autoimmune
arthritis in mice.
Nature.
2003;
426
(6965)
454-460
MissingFormLabel
- 18
Gong Q, Cheng A M, Akk A M et al..
Disruption of T cell signaling networks and development by Grb2 haploid insufficiency.
Nat Immunol.
2001;
2
(1)
29-36
MissingFormLabel
- 19
McCarty N, Paust S, Ikizawa K, Dan I, Li X, Cantor H.
Signaling by the kinase MINK is essential in the negative selection of autoreactive
thymocytes.
Nat Immunol.
2005;
6
(1)
65-72
MissingFormLabel
- 20
Olsson B, Andersson P O, Jacobsson S, Carlsson L, Wadenvik H.
Disturbed apoptosis of T-cells in patients with active idiopathic thrombocytopenic
purpura.
Thromb Haemost.
2005;
93
(1)
139-144
MissingFormLabel
- 21
Olsson B, Andersson P O, Jernås M et al..
T-cell-mediated cytotoxicity toward platelets in chronic idiopathic thrombocytopenic
purpura.
Nat Med.
2003;
9
(9)
1123-1124
MissingFormLabel
- 22
Salgame P, Abrams J S, Clayberger C et al..
Differing lymphokine profiles of functional subsets of human CD4 and CD8 T cell clones.
Science.
1991;
254
(5029)
279-282
MissingFormLabel
- 23
Romagnani S.
Th1 and Th2 in human diseases.
Clin Immunol Immunopathol.
1996;
80
(3 Pt 1)
225-235
MissingFormLabel
- 24
Mosmann T R, Coffman R L.
TH1 and TH2 cells: different patterns of lymphokine secretion lead to different functional
properties.
Annu Rev Immunol.
1989;
7
145-173
MissingFormLabel
- 25
Mosmann T R, Sad S.
The expanding universe of T-cell subsets: Th1, Th2 and more.
Immunol Today.
1996;
17
(3)
138-146
MissingFormLabel
- 26
Liblau R S, Singer S M, McDevitt H O.
Th1 and Th2 CD4 + T cells in the pathogenesis of organ-specific autoimmune diseases.
Immunol Today.
1995;
16
(1)
34-38
MissingFormLabel
- 27
Druet P, Sheela R, Pelletier L.
Th1 and Th2 cells in autoimmunity.
Clin Exp Immunol.
1995;
101
(Suppl 1)
9-12
MissingFormLabel
- 28
Semple J W, Milev Y, Cosgrave D et al..
Differences in serum cytokine levels in acute and chronic autoimmune thrombocytopenic
purpura: relationship to platelet phenotype and antiplatelet T-cell reactivity.
Blood.
1996;
87
(10)
4245-4254
MissingFormLabel
- 29
Panitsas F P, Theodoropoulou M, Kouraklis A et al..
Adult chronic idiopathic thrombocytopenic purpura (ITP) is the manifestation of a
type-1 polarized immune response.
Blood.
2004;
103
(7)
2645-2647
MissingFormLabel
- 30
Ogawara H, Handa H, Morita K et al..
High Th1/Th2 ratio in patients with chronic idiopathic thrombocytopenic purpura.
Eur J Haematol.
2003;
71
(4)
283-288
MissingFormLabel
- 31
Gu D, Chen Z, Zhao H et al..
Th1 (CXCL10) and Th2 (CCL2) chemokine expression in patients with immune thrombocytopenia.
Hum Immunol.
2010;
71
(6)
586-591
MissingFormLabel
- 32
Zhang J, Ma D, Zhu X, Qu X, Ji C, Hou M.
Elevated profile of Th17, Th1 and Tc1 cells in patients with immune thrombocytopenic
purpura.
Haematologica.
2009;
94
(9)
1326-1329
MissingFormLabel
- 33
Zhu X, Ma D, Zhang J et al..
Elevated interleukin-21 correlated to Th17 and Th1 cells in patients with immune thrombocytopenia.
J Clin Immunol.
2010;
30
(2)
253-259
MissingFormLabel
- 34
Huetz F, Carlsson L, Tornberg U C, Holmberg D.
V-region directed selection in differentiating B lymphocytes.
EMBO J.
1993;
12
(5)
1819-1826
MissingFormLabel
- 35
Yancopoulos G D, Alt F W.
Regulation of the assembly and expression of variable-region genes.
Annu Rev Immunol.
1986;
4
339-368
MissingFormLabel
- 36
Tonegawa S.
Somatic generation of antibody diversity.
Nature.
1983;
302
(5909)
575-581
MissingFormLabel
- 37
Fischer P, Jendreyko N, Hoffmann M et al..
Platelet-reactive IgG antibodies cloned by phage display and panning with IVIG from
three patients with autoimmune thrombocytopenia.
Br J Haematol.
1999;
105
(3)
626-640
MissingFormLabel
- 38
Roark J H, Bussel J B, Cines D B, Siegel D L.
Genetic analysis of autoantibodies in idiopathic thrombocytopenic purpura reveals
evidence of clonal expansion and somatic mutation.
Blood.
2002;
100
(4)
1388-1398
MissingFormLabel
- 39
van Dijk-Härd I, Feld S, Holmberg D, Lundkvist I.
Increased utilization of the VH6 gene family in patients with autoimmune idiopathic
thrombocytopenic purpura.
J Autoimmun.
1999;
12
(1)
57-63
MissingFormLabel
- 40
Söderström I, van Dijk-Härd I, Feld S, Hillörn V, Holmberg D, Lundkvist I.
Altered VH6-D-JH repertoire in human insulin-dependent diabetes mellitus and autoimmune
idiopathic thrombocytopenic purpura.
Eur J Immunol.
1999;
29
(9)
2853-2862
MissingFormLabel
- 41
Kato T, Kurokawa M, Sasakawa H et al..
Analysis of accumulated T cell clonotypes in patients with systemic lupus erythematosus.
Arthritis Rheum.
2000;
43
(12)
2712-2721
MissingFormLabel
- 42
Matsumoto Y, Yoon W K, Jee Y et al..
Complementarity-determining region 3 spectratyping analysis of the TCR repertoire
in multiple sclerosis.
J Immunol.
2003;
170
(9)
4846-4853
MissingFormLabel
- 43
Sun W, Nie H, Li N et al..
Skewed T-cell receptor BV14 and BV16 expression and shared CDR3 sequence and common
sequence motifs in synovial T cells of rheumatoid arthritis.
Genes Immun.
2005;
6
(3)
248-261
MissingFormLabel
- 44
Hedlund-Treutiger I, Elinder G, Wigzell H, Grunewald J, Wahlström J.
T cell receptor V gene usage by CD4+ and CD8+ peripheral blood T lymphocytes in immune thrombocytopenic purpura.
Acta Paediatr.
2004;
93
(5)
633-637
MissingFormLabel
- 45
Shimomura T, Fujimura K, Takafuta T et al..
Oligoclonal accumulation of T cells in peripheral blood from patients with idiopathic
thrombocytopenic purpura.
Br J Haematol.
1996;
95
(4)
732-737
MissingFormLabel
- 46
Zhang X L, Li Y Q, Chen S H et al..
The feature of clonal expansion of TCR Vbeta repertoire, thymic recent output function
and TCRzeta chain expression in patients with immune thrombocytopenic purpura.
Int J Lab Hematol.
2009;
31
(6)
639-648
MissingFormLabel
- 47
Stasi R, Del Poeta G, Stipa E et al..
Response to B-cell depleting therapy with rituximab reverts the abnormalities of T-cell
subsets in patients with idiopathic thrombocytopenic purpura.
Blood.
2007;
110
(8)
2924-2930
MissingFormLabel
- 48
Rui L, Vinuesa C G, Blasioli J, Goodnow C C.
Resistance to CpG DNA-induced autoimmunity through tolerogenic B cell antigen receptor
ERK signaling.
Nat Immunol.
2003;
4
(6)
594-600
MissingFormLabel
- 49
Carreno B M, Bennett F, Chau T A et al..
CTLA-4 (CD152) can inhibit T cell activation by two different mechanisms depending
on its level of cell surface expression.
J Immunol.
2000;
165
(3)
1352-1356
MissingFormLabel
- 50
Peng J, Liu C, Liu D et al..
Effects of B7-blocking agent and/or CsA on induction of platelet-specific T-cell anergy
in chronic autoimmune thrombocytopenic purpura.
Blood.
2003;
101
(7)
2721-2726
MissingFormLabel
- 51
Zhang X L, Peng J, Sun J Z et al..
Modulation of immune response with cytotoxic T-lymphocyte-associated antigen 4 immunoglobulin-induced
anergic T cells in chronic idiopathic thrombocytopenic purpura.
J Thromb Haemost.
2008;
6
(1)
158-165
MissingFormLabel
- 52
von Boehmer H.
Mechanisms of suppression by suppressor T cells.
Nat Immunol.
2005;
6
(4)
338-344
MissingFormLabel
- 53
Mellanby R J, Thomas D C, Lamb J.
Role of regulatory T-cells in autoimmunity.
Clin Sci (Lond).
2009;
116
(8)
639-649
MissingFormLabel
- 54
Sakakura M, Wada H, Tawara I et al..
Reduced Cd4+ Cd25+ T cells in patients with idiopathic thrombocytopenic purpura.
Thromb Res.
2007;
120
(2)
187-193
MissingFormLabel
- 55
Yu J, Heck S, Patel V et al..
Defective circulating CD25 regulatory T cells in patients with chronic immune thrombocytopenic
purpura.
Blood.
2008;
112
(4)
1325-1328
MissingFormLabel
- 56
Ling Y, Cao X, Yu Z, Ruan C.
Circulating dendritic cells subsets and CD4 + Foxp3 + regulatory T cells in adult
patients with chronic ITP before and after treatment with high-dose dexamethasome.
Eur J Haematol.
2007;
79
(4)
310-316
MissingFormLabel
- 57
Stasi R, Cooper N, Del Poeta G et al..
Analysis of regulatory T-cell changes in patients with idiopathic thrombocytopenic
purpura receiving B cell-depleting therapy with rituximab.
Blood.
2008;
112
(4)
1147-1150
MissingFormLabel
- 58
Li Z, Mou W, Lu G et al..
Low-dose rituximab combined with short-term glucocorticoids up-regulates Treg cell
levels in patients with immune thrombocytopenia.
Int J Hematol.
2011;
93
(1)
91-98
MissingFormLabel
- 59
Bao W, Bussel J B, Heck S et al..
Improved regulatory T-cell activity in patients with chronic immune thrombocytopenia
treated with thrombopoietic agents.
Blood.
2010;
116
(22)
4639-4645
MissingFormLabel
- 60
Semple J W, Freedman J.
Increased antiplatelet T helper lymphocyte reactivity in patients with autoimmune
thrombocytopenia.
Blood.
1991;
78
(10)
2619-2625
MissingFormLabel
- 61
Kuwana M, Kaburaki J, Kitasato H et al..
Immunodominant epitopes on glycoprotein IIb-IIIa recognized by autoreactive T cells
in patients with immune thrombocytopenic purpura.
Blood.
2001;
98
(1)
130-139
MissingFormLabel
- 62
Sukati H, Watson H G, Urbaniak S J, Barker R N.
Mapping helper T-cell epitopes on platelet membrane glycoprotein IIIa in chronic autoimmune
thrombocytopenic purpura.
Blood.
2007;
109
(10)
4528-4538
MissingFormLabel
- 63
Aster R H.
Molecular mimicry and immune thrombocytopenia.
Blood.
2009;
113
(17)
3887-3888
MissingFormLabel
- 64
Stasi R, Sarpatwari A, Segal J B et al..
Effects of eradication of Helicobacter pylori infection in patients with immune thrombocytopenic
purpura: a systematic review.
Blood.
2009;
113
(6)
1231-1240
MissingFormLabel
- 65
Arnold D M, Bernotas A, Nazi I et al..
Platelet count response to H. pylori treatment in patients with immune thrombocytopenic
purpura with and without H. pylori infection: a systematic review.
Haematologica.
2009;
94
(6)
850-856
MissingFormLabel
- 66
Takahashi T, Yujiri T, Shinohara K et al..
Molecular mimicry by Helicobacter pylori CagA protein may be involved in the pathogenesis
of H. pylori-associated chronic idiopathic thrombocytopenic purpura.
Br J Haematol.
2004;
124
(1)
91-96
MissingFormLabel
- 67
Maeda S, Ogura K, Yoshida H et al..
Major virulence factors, VacA and CagA, are commonly positive in Helicobacter pylori
isolates in Japan.
Gut.
1998;
42
(3)
338-343
MissingFormLabel
- 68
Nardi M A, Liu L X, Karpatkin S.
GPIIIa-(49-66) is a major pathophysiologically relevant antigenic determinant for
anti-platelet GPIIIa of HIV-1-related immunologic thrombocytopenia.
Proc Natl Acad Sci U S A.
1997;
94
(14)
7589-7594
MissingFormLabel
- 69
Li Z, Nardi M A, Karpatkin S.
Role of molecular mimicry to HIV-1 peptides in HIV-1-related immunologic thrombocytopenia.
Blood.
2005;
106
(2)
572-576
MissingFormLabel
- 70
Karpatkin S, Nardi M.
Autoimmune anti-HIV-1gp120 antibody with antiidiotype-like activity in sera and immune
complexes of HIV-1-related immunologic thrombocytopenia.
J Clin Invest.
1992;
89
(2)
356-364
MissingFormLabel
- 71
Nardi M, Tomlinson S, Greco M A, Karpatkin S.
Complement-independent, peroxide-induced antibody lysis of platelets in HIV-1-related
immune thrombocytopenia.
Cell.
2001;
106
(5)
551-561
MissingFormLabel
- 72
Sakaguchi M, Sato T, Groopman J E.
Human immunodeficiency virus infection of megakaryocytic cells.
Blood.
1991;
77
(3)
481-485
MissingFormLabel
- 73
Sundell I B, Koka P S.
Thrombocytopenia in HIV infection: impairment of platelet formation and loss correlates
with increased c-Mpl and ligand thrombopoietin expression.
Curr HIV Res.
2006;
4
(1)
107-116
MissingFormLabel
- 74
Zhang W, Nardi M A, Borkowsky W, Li Z, Karpatkin S.
Role of molecular mimicry of hepatitis C virus protein with platelet GPIIIa in hepatitis
C-related immunologic thrombocytopenia.
Blood.
2009;
113
(17)
4086-4093
MissingFormLabel
- 75
Ballem P J, Segal G M, Stratton J R, Gernsheimer T, Adamson J W, Slichter S J.
Mechanisms of thrombocytopenia in chronic autoimmune thrombocytopenic purpura. Evidence
of both impaired platelet production and increased platelet clearance.
J Clin Invest.
1987;
80
(1)
33-40
MissingFormLabel
- 76
Kuter D J, Rummel M, Boccia R et al..
Romiplostim or standard of care in patients with immune thrombocytopenia.
N Engl J Med.
2010;
363
(20)
1889-1899
MissingFormLabel
- 77
Cheng G, Saleh M N, Marcher C et al..
Eltrombopag for management of chronic immune thrombocytopenia (RAISE): a 6-month,
randomised, phase 3 study.
Lancet.
2011;
377
(9763)
393-402
MissingFormLabel
- 78
Dighiero G, Lymberi P, Guilbert B, Ternynck T, Avrameas S.
Natural autoantibodies constitute a substantial part of normal circulating immunoglobulins.
Ann N Y Acad Sci.
1986;
475
135-145
MissingFormLabel
- 79
Filion M C, Proulx C, Bradley A J et al..
Presence in peripheral blood of healthy individuals of autoreactive T cells to a membrane
antigen present on bone marrow-derived cells.
Blood.
1996;
88
(6)
2144-2150
MissingFormLabel
- 80
Shlomchik M J, Marshak-Rothstein A, Wolfowicz C B, Rothstein T L, Weigert M G.
The role of clonal selection and somatic mutation in autoimmunity.
Nature.
1987;
328
(6133)
805-811
MissingFormLabel
- 81
Tsubakio T, Tani P, Woods Jr V L, McMillan R.
Autoantibodies against platelet GPIIb/IIIa in chronic ITP react with different epitopes.
Br J Haematol.
1987;
67
(3)
345-348
MissingFormLabel
- 82
Harrington W J, Minnich V, Hollingsworth J W, Moore C V.
Demonstration of a thrombocytopenic factor in the blood of patients with thrombocytopenic
purpura.
J Lab Clin Med.
1951;
38
(1)
1-10
MissingFormLabel
- 83
Luk S C, Musclow E, Simon G T.
Platelet phagocytosis in the spleen of patients with idiopathic thrombocytopenic purpura
(ITP).
Histopathology.
1980;
4
(2)
127-136
MissingFormLabel
- 84
Panzer S, Szamait S, Bödeker R H, Haas O A, Haubenstock A, Mueller-Eckhardt C.
Platelet-associated immunoglobulins IgG, IgM, IgA and complement C3 in immune and
nonimmune thrombocytopenic disorders.
Am J Hematol.
1986;
23
(2)
89-99
MissingFormLabel
- 85
Piguet P F, Vesin C.
Modulation of platelet caspases and life-span by anti-platelet antibodies in mice.
Eur J Haematol.
2002;
68
(5)
253-261
MissingFormLabel
- 86
Leytin V, Mykhaylov S, Starkey A F et al..
Intravenous immunoglobulin inhibits anti-glycoprotein IIb-induced platelet apoptosis
in a murine model of immune thrombocytopenia.
Br J Haematol.
2006;
133
(1)
78-82
MissingFormLabel
- 87
Usuki Y, Kohsaki M, Nagai K, Ohe Y, Hara H.
Complement-dependent cytotoxic factor to megakaryocyte progenitors in sera from patients
with idiopathic thrombocytopenic purpura.
Int J Cell Cloning.
1986;
4
(6)
447-463
MissingFormLabel
- 88
Takahashi R, Sekine N, Nakatake T.
Influence of monoclonal antiplatelet glycoprotein antibodies on in vitro human megakaryocyte
colony formation and proplatelet formation.
Blood.
1999;
93
(6)
1951-1958
MissingFormLabel
- 89
Alimardani G, Guichard J, Fichelson S, Cramer E M.
Pathogenic effects of anti-glycoprotein Ib antibodies on megakaryocytes and platelets.
Thromb Haemost.
2002;
88
(6)
1039-1046
MissingFormLabel
- 90
Karpatkin S.
Autoimmune thrombocytopenic purpura.
Blood.
1980;
56
(3)
329-343
MissingFormLabel
- 91
Kelton J G, Gibbons S.
Autoimmune platelet destruction: idiopathic thrombocytopenic purpura.
Semin Thromb Hemost.
1982;
8
(2)
83-104
MissingFormLabel
- 92
Isaka Y, Kambayashi J, Kimura K et al..
Platelet production, clearance and distribution in patients with idiopathic thrombocytopenic
purpura.
Thromb Res.
1990;
60
(2)
121-131
MissingFormLabel
- 93
Cooper N.
Intravenous immunoglobulin and anti-RhD therapy in the management of immune thrombocytopenia.
Hematol Oncol Clin North Am.
2009;
23
(6)
1317-1327
MissingFormLabel
- 94
Kelton J G, Singer J, Rodger C, Gauldie J, Horsewood P, Dent P.
The concentration of IgG in the serum is a major determinant of Fc-dependent reticuloendothelial
function.
Blood.
1985;
66
(3)
490-495
MissingFormLabel
- 95
Kojouri K, Vesely S K, Terrell D R, George J N.
Splenectomy for adult patients with idiopathic thrombocytopenic purpura: a systematic
review to assess long-term platelet count responses, prediction of response, and surgical
complications.
Blood.
2004;
104
(9)
2623-2634
MissingFormLabel
- 96
Sarpatwari A, Provan D, Erqou S, Sobnack R, David Tai F W, Newland A C.
Autologous 111 In-labelled platelet sequestration studies in patients with primary
immune thrombocytopenia (ITP) prior to splenectomy: a report from the United Kingdom
ITP Registry.
Br J Haematol.
2010;
151
(5)
477-487
MissingFormLabel
- 97
Peerschke E I, Andemariam B, Yin W, Bussel J B.
Complement activation on platelets correlates with a decrease in circulating immature
platelets in patients with immune thrombocytopenic purpura.
Br J Haematol.
2010;
148
(4)
638-645
MissingFormLabel
- 98
Jin Z, El-Deiry W S.
Overview of cell death signaling pathways.
Cancer Biol Ther.
2005;
4
(2)
139-163
MissingFormLabel
- 99
Falcieri E, Bassini A, Pierpaoli S et al..
Ultrastructural characterization of maturation, platelet release, and senescence of
human cultured megakaryocytes.
Anat Rec.
2000;
258
(1)
90-99
MissingFormLabel
- 100
Kaluzhny Y, Yu G, Sun S et al..
BclxL overexpression in megakaryocytes leads to impaired platelet fragmentation.
Blood.
2002;
100
(5)
1670-1678
MissingFormLabel
- 101
Bouillet P, Metcalf D, Huang D C et al..
Proapoptotic Bcl-2 relative Bim required for certain apoptotic responses, leukocyte
homeostasis, and to preclude autoimmunity.
Science.
1999;
286
(5445)
1735-1738
MissingFormLabel
- 102
De Botton S, Sabri S, Daugas E et al..
Platelet formation is the consequence of caspase activation within megakaryocytes.
Blood.
2002;
100
(4)
1310-1317
MissingFormLabel
- 103
Morison I M, Cramer Bordé E M, Cheesman E J et al..
A mutation of human cytochrome c enhances the intrinsic apoptotic pathway but causes
only thrombocytopenia.
Nat Genet.
2008;
40
(4)
387-389
MissingFormLabel
- 104
Chang M, Nakagawa P A, Williams S A et al..
Immune thrombocytopenic purpura (ITP) plasma and purified ITP monoclonal autoantibodies
inhibit megakaryocytopoiesis in vitro.
Blood.
2003;
102
(3)
887-895
MissingFormLabel
- 105
McMillan R, Wang L, Tomer A, Nichol J, Pistillo J.
Suppression of in vitro megakaryocyte production by antiplatelet autoantibodies from
adult patients with chronic ITP.
Blood.
2004;
103
(4)
1364-1369
MissingFormLabel
- 106
Houwerzijl E J, Blom N R, van der Want J J et al..
Ultrastructural study shows morphologic features of apoptosis and para-apoptosis in
megakaryocytes from patients with idiopathic thrombocytopenic purpura.
Blood.
2004;
103
(2)
500-506
MissingFormLabel
- 107
Kaushansky K.
Thrombopoietin.
N Engl J Med.
1998;
339
(11)
746-754
MissingFormLabel
- 108
Borge O J, Ramsfjell V, Veiby O P, Murphy Jr M J, Lok S, Jacobsen S E.
Thrombopoietin, but not erythropoietin promotes viability and inhibits apoptosis of
multipotent murine hematopoietic progenitor cells in vitro.
Blood.
1996;
88
(8)
2859-2870
MissingFormLabel
- 109
Houwerzijl E J, Blom N R, van der Want J J, Vellenga E, de Wolf J T.
Megakaryocytic dysfunction in myelodysplastic syndromes and idiopathic thrombocytopenic
purpura is in part due to different forms of cell death.
Leukemia.
2006;
20
(11)
1937-1942
MissingFormLabel
- 110
Yang L, Wang L, Zhao C H et al..
Contributions of TRAIL-mediated megakaryocyte apoptosis to impaired megakaryocyte
and platelet production in immune thrombocytopenia.
Blood.
2010;
116
(20)
4307-4316
MissingFormLabel
- 111
Zhang F, Chu X, Wang L et al..
Cell-mediated lysis of autologous platelets in chronic idiopathic thrombocytopenic
purpura.
Eur J Haematol.
2006;
76
(5)
427-431
MissingFormLabel
- 112
Chow L, Aslam R, Speck E R et al..
A murine model of severe immune thrombocytopenia is induced by antibody- and CD8 + T
cell-mediated responses that are differentially sensitive to therapy.
Blood.
2010;
115
(6)
1247-1253
MissingFormLabel
- 113
Li S, Wang L, Zhao C, Li L, Peng J, Hou M.
CD8+ T cells suppress autologous megakaryocyte apoptosis in idiopathic thrombocytopenic
purpura.
Br J Haematol.
2007;
139
(4)
605-611
MissingFormLabel
Donald M ArnoldM.D.C.M. M.Sc.
Department of Medicine, McMaster University, 1280 Main Street West
HSC 3V50, Hamilton, ON L8S 4K1 Canada
eMail: arnold@mcmaster.ca